Journal of Molecular and Genetic medicine is top journals of Alzheimer's disease. It is an international, peer reviewed, Open access journals that provides a platform for the researchers to share their research and experience to the worldwide for the benefits of people. This Journal is established to advertise and energize advancement and progression of Alzheimer's disease.
Journal of Molecular and Genetic medicine intends to impart the enhanced clinical profits for human wellbeing from the trial and translational exploration performed utilizing molecular tools. Areas that are secured incorporate, yet are not restricted to, tumor science, immunology, neuroscience, cardiovascular disease, heredity and genomics, gene therapy and stem cells and regenerative medicine.
OMICS Group Journals encourages original and well researched articles for publication. With the help of a strong 25, 000 experts as editorial board members and reviewers, OMICS Group journals uphold the standard review process. We have more than 50,000+ editorial board members and more than 15 million readers. It has more than 700+ peer-reviewed journals and organizes more than 3000+ International Scientific Conferences.
Last date updated on June, 2014